A detailed history of Norinchukin Bank, The transactions in Abbott Laboratories stock. As of the latest transaction made, Norinchukin Bank, The holds 66,264 shares of ABT stock, worth $7.57 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
66,264
Previous 59,422 11.51%
Holding current value
$7.57 Million
Previous $6.17 Million 22.35%
% of portfolio
0.18%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $684,678 - $808,245
6,842 Added 11.51%
66,264 $7.55 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $115,839 - $129,306
1,150 Added 1.97%
59,422 $6.17 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $83,235 - $91,929
-760 Reduced 1.29%
58,272 $6.62 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $253,794 - $310,665
-2,814 Reduced 4.55%
59,032 $6.5 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $5.91 Million - $7.09 Million
61,846 New
61,846 $5.99 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $461,068 - $513,726
4,575 Added 4.81%
99,773 $10.9 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $330,292 - $388,774
3,410 Added 3.72%
95,198 $9.64 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $1.09 Million - $1.28 Million
-11,442 Reduced 11.08%
91,788 $10.1 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $582,882 - $674,868
6,024 Added 6.2%
103,230 $9.99 Million
Q2 2022

Aug 10, 2022

SELL
$102.07 - $123.37 $6.39 Million - $7.72 Million
-62,578 Reduced 39.16%
97,206 $10.6 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $1.1 Million - $1.34 Million
9,637 Added 6.42%
159,784 $18.9 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $153,654 - $188,141
-1,330 Reduced 0.88%
150,147 $21.1 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $519,836 - $575,091
4,456 Added 3.03%
151,477 $17.9 Million
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $35,016 - $41,219
-331 Reduced 0.22%
147,021 $17 Million
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $250,005 - $294,544
2,297 Added 1.58%
147,352 $17.7 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $454,440 - $495,209
-4,328 Reduced 2.9%
145,055 $15.9 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $264,839 - $321,628
2,890 Added 1.97%
149,383 $16.3 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $108,040 - $138,278
-1,411 Reduced 0.95%
146,493 $13.4 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $8.66 Million - $12.7 Million
-137,905 Reduced 48.25%
147,904 $11.7 Million
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $1.67 Million - $1.86 Million
-21,250 Reduced 6.92%
285,809 $24.8 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $483,428 - $524,187
5,907 Added 1.96%
307,059 $25.7 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $8.93 Million - $10.4 Million
-122,471 Reduced 28.91%
301,152 $25.3 Million
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $766,562 - $926,774
11,576 Added 2.81%
423,623 $33.9 Million
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $6.32 Million - $7.16 Million
96,430 Added 30.55%
412,047 $29.8 Million
Q3 2018

Nov 08, 2018

BUY
$60.81 - $73.36 $1.63 Million - $1.96 Million
26,729 Added 9.25%
315,617 $23.2 Million
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $2.26 Million - $2.5 Million
39,305 Added 15.75%
288,888 $17.6 Million
Q1 2018

May 10, 2018

BUY
$56.27 - $63.62 $1.2 Million - $1.36 Million
21,303 Added 9.33%
249,583 $15 Million
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $531,593 - $569,125
9,903 Added 4.53%
228,280 $13 Million
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $10.5 Million - $11.7 Million
218,377
218,377 $11.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.